Abstract
Pacemaker vendor was contacted and confirmed there were no reported Mycobacterium infections related to the device. No further Mycobacterium Fortuitum infections have been identified. LESSON LEARNED: The use of cardiac implantable electrophysiological device (CIED) implantation for the management of cardiac disease is increasing as are infections associated with these procedures. Mitigation of infection risk can be accomplished through teamwork and sustained follow up of instituted Infection Prevention measures. Supplemental cleaning support by Electrophysiology Lab staff is useful in high-volume procedure rooms. Forging interdepartmental collaborative teams to identify and address opportunities for improvement can result in enhanced patient outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
